JPS53117215A
(en)
*
|
1977-03-24 |
1978-10-13 |
Hideyoshi Morita |
Earthquakeeproof steel beam
|
ES8101067A1
(es)
*
|
1978-08-25 |
1980-12-01 |
Thomae Gmbh Dr K |
Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
|
US4258185A
(en)
*
|
1978-10-17 |
1981-03-24 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridazinone compounds
|
DE2935359A1
(de)
*
|
1979-09-01 |
1981-03-26 |
Basf Ag |
6-imidazolyl-3-hydrazino-pyridazine
|
DE3006671A1
(de)
*
|
1980-02-22 |
1981-08-27 |
Thomae Gmbh Dr K |
Neue benzoxazole, deren herstellung und deren verwendung als arzneumittel
|
US4699909A
(en)
*
|
1981-07-25 |
1987-10-13 |
Dr. Karl Thomae Gmbh |
Benzotriazolyl-4,5-dihydro-3(2H)-pyridazinones
|
DE3129447A1
(de)
*
|
1981-07-25 |
1983-02-10 |
Thomae Gmbh Dr K |
"neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel"
|
US4840955A
(en)
*
|
1984-12-24 |
1989-06-20 |
Warner-Lambert Company |
6-substituted-2(1H)-quinolinones and related compounds having use as cardiotonic, antihypertensive, and antithrombotic agents
|
ZA8509091B
(en)
*
|
1984-12-24 |
1987-07-29 |
Warner Lambert Co |
Novel 6-substituted-2 (1h)-quinolinones and related compounds having use as cardiotonic,anti-hypertensive,and anti-thrombotic agents
|
US4785101A
(en)
*
|
1985-11-22 |
1988-11-15 |
Rorer Pharmaceutical Corporation |
Benzodiazinone-hydroxypyrazolyl compounds, cardiotonic compositions including the same and their uses
|
US4868300A
(en)
*
|
1985-11-22 |
1989-09-19 |
Rorer Pharmaceutical Corporation |
Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
|
US4725686A
(en)
*
|
1985-11-22 |
1988-02-16 |
William H. Rorer, Inc. |
Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
|
US4906630A
(en)
*
|
1985-11-22 |
1990-03-06 |
Rorer Pharmaceutical Corporation |
Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
|
JPH0533729B2
(xx)
*
|
1986-04-21 |
1993-05-20 |
Anritsu Corp |
|
JPH0549049B2
(xx)
*
|
1986-04-21 |
1993-07-23 |
Anritsu Corp |
|
US4859672A
(en)
*
|
1986-10-29 |
1989-08-22 |
Rorer Pharmaceutical Corporation |
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
|
US5002944A
(en)
*
|
1986-10-29 |
1991-03-26 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having cardiotonic activity
|
JPS63181827U
(xx)
*
|
1987-05-13 |
1988-11-24 |
|
|
DE4237656A1
(de)
*
|
1992-06-13 |
1993-12-16 |
Merck Patent Gmbh |
Benzimidazolderivate
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
US6162804A
(en)
*
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
CA2347939C
(en)
*
|
1998-10-23 |
2006-10-10 |
Akira Matsumori |
Composition for the treatment of rheumatism, hepatitis or pancreatitis
|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
US20030236259A1
(en)
*
|
2002-02-05 |
2003-12-25 |
Rolf Hohlweg |
Novel aryl- and heteroarylpiperazines
|
EP1799664A1
(en)
*
|
2004-09-20 |
2007-06-27 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
TW200626148A
(en)
*
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
WO2006034279A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
TW200626592A
(en)
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
EP1807085B1
(en)
|
2004-09-20 |
2013-08-21 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
EP2316458A1
(en)
|
2004-09-20 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
TW200626572A
(en)
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
AU2005329423A1
(en)
*
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
JP4714921B2
(ja)
*
|
2005-02-14 |
2011-07-06 |
トーアエイヨー株式会社 |
ピモベンダンの製造法及びその中間体
|
US8541457B2
(en)
*
|
2005-06-03 |
2013-09-24 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
|
WO2007003604A2
(en)
|
2005-07-04 |
2007-01-11 |
Novo Nordisk A/S |
Hists1mine h3 receptor antagonists
|
US7816542B2
(en)
*
|
2005-08-15 |
2010-10-19 |
Irm Llc |
Compounds and compositions as TPO mimetics
|
SG163547A1
(en)
*
|
2006-05-29 |
2010-08-30 |
High Point Pharmaceuticals Llc |
3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
|
EP2014656A3
(en)
*
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
US20120022057A1
(en)
|
2009-03-18 |
2012-01-26 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
|
US8729263B2
(en)
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
KR20160037199A
(ko)
*
|
2013-07-31 |
2016-04-05 |
노파르티스 아게 |
1,4-이치환된 피리다진 유사체 및 smn-결핍-관련 상태를 치료하기 위한 그의 용도
|
WO2018086703A1
(en)
*
|
2016-11-11 |
2018-05-17 |
Bayer Pharma Aktiengesellschaft |
Dihydropyridazinones substituted with phenylureas
|